Key result
Preventive strategies aim to mitigate adverse cardiovascular effects in patients undergoing cancer therapy.
Key points are not available for this paper at this time.
Preventive strategies for cardiotoxicity lack proven efficacy in most settings; leaves open optimal selection and timing for future trials.
[Figure: see text]
No takes yet. Share an insight, caveat, or question.
Cannatà et al. (2024) studied this question. Preventive strategies for cancer therapy-related cardiotoxicity aim to mitigate adverse cardiovascular effects in patients undergoing oncological treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: